Child Vaccination Hesitancy

Child vaccination hesitancy has led to a significant decrease in vaccine-preventable diseases, such as measles, mumps, rubella and others. However, some parents may have concerns about the safety, effectiveness and necessity of vaccines. The pediatric infectious disease specialists with Norton Children’s Infectious Diseases, affiliated with the UofL School of Medicine, can help parents experiencing vaccine hesitancy.

What Is Child Vaccination Hesitancy?

Vaccine hesitancy is when parents may have a lack of trust in the medical community; concerns about the safety, effectiveness and necessity of vaccines; or other issues related to vaccination. Vaccine hesitancy can contribute to children being undervaccinated or not vaccinated due to parents’ decisions to delay or refuse vaccines for their children.

Choosing not to vaccinate a child has risks for the child as well as people that come into contact with the child. As more parents choose not to vaccinate their children, it reduces “herd immunity,” a safe vaccination rate that can help lower the spread of infectious diseases within a community.

The pediatric infectious disease specialists with Norton Children’s Infectious Diseases can work with families who are concerned about vaccinations. Our providers are up to date on the latest information about vaccine safety and best practices, and can give evidence-based information and recommendations on concerns families may have.

Why Choose Norton Children’s Infectious Diseases?

  • Norton Children’s Infectious Diseases specializes in the care of children from birth through adolescence.
  • With seven infectious diseases specialists and one nurse practitioner on staff, your child can be seen quickly, especially for urgent needs.
  • Members of our team are nationally recognized and have held or serve in leadership positions related to infectious diseases.
  • Our provider team is leading Norton Children’s Hospital and Norton Children’s Medical Group in COVID-19 efforts, helping streamline infection prevention and providing patient care during the pandemic.
  • Our team provides inpatient consultation services at Norton Children’s Hospital and Norton Women’s & Children’s Hospital, as well as telemedicine services throughout Kentucky. Our physicians also treat patients at UofL Hospital.
  • Keep up with your child’s lab results, communicate with your provider and schedule appointments through MyNortonChart.
Infectious Disease – 5437

Norton Children’s Infectious Diseases

Call for Information

(502) 588-2348

Symptoms of hand, foot and mouth disease

Hand, foot and mouth disease symptoms include the small red sores that often appear in the mouth and rashes that appear on the palms of the hands and soles of the feet and that give […]

Read Full Story

Respiratory syncytial virus (RSV) in infants can lead to respiratory conditions later

There is increasing evidence that severe respiratory syncytial virus (RSV) infections in young children can have long-term effects such as wheezing and asthma, according to Ronald L. Morton, M.D.,  pediatric pulmonologist with Norton Children’s Pulmonology, […]

Read Full Story

Summertime RSV outbreak may signal prolonged traditional RSV season

The respiratory syncytial virus (RSV) outbreak of 2021 brought unprecedented summertime levels of the infection to states like Kentucky, raising some concerns about the traditional cold-weather season for RSV. At Norton Children’s, health care providers […]

Read Full Story

Local cases of RSV, croup on the rise

While most virus news continues to be about the one that causes COVID-19, there are several other viruses affecting local children. Last week, the Centers for Disease Control and Prevention (CDC) issued a health advisory […]

Read Full Story

Norton Children’s Research Institute, affiliated with the UofL School of Medicine, to participate in COVID-19 investigational vaccine clinical trial for children ages 6 months to 4 years

The Norton Children’s Research Institute, affiliated with the UofL School of Medicine, will participate in a phase 2/3 clinical trial of the Pfizer-BioNTech COVID-19 investigational vaccine for healthy children ages 6 months to 4 years. […]

Read Full Story

Search our entire site.